Jean Macino - 10 Aug 2023 Form 4 Insider Report for CORVEL CORP (CRVL)

Reporting relationship
Director
Issuer ticker
CRVL
Reported as of
10 Aug 2023
Net transaction value
-$442,043
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Aug 2023, 18:06:46 UTC
Prior SEC filing
19 Jul 2023
Next SEC filing
26 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Sharon O'Connor For: Jean Macino

Key filing fact

Jean Macino filed Form 4 for CORVEL CORP (CRVL) on 14 Aug 2023.

Key facts

  • This page summarizes Jean Macino's Form 4 filing for CORVEL CORP (CRVL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Aug 2023, 18:06.

Change

  • Previous filing in this sequence was filed on 19 Jul 2023.
  • Current net transaction value: -$442,043.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVL transaction

Common Stock

Sale

Transaction value
$442,043
Shares
-2,000
Change %
-10%
Price
$221.02
Shares after
17,290
Date
10 Aug 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
$0
Shares
+500
Change %
Price
$0.000000
Shares after
500
Date
10 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500
Exercise price
$222.26
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .